NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NovoCure Ltd (NVCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5153
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer and small cell lung cancer, among others. It also offers provides products for other indications such as glioblastoma and diagnosed glioblastoma, among others. Novocure owns and operates a research centre in Haifa, Israel; and operates along with its subsidiaries located in the US; Berlin, and Germany. The company has its operations in Japan and Switzerland. NovoCure is headquartered in St. Helier, the UK.

NovoCure Ltd (NVCR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NovoCure Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novocure Enters into Agreement with US Oncology Research 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 12
Equity Offering 13
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Ltd – Key Competitors 16
NovoCure Ltd – Key Employees 17
NovoCure Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Apr 26, 2018: Novocure Reports First Quarter 2018 Financial Results and Provides Company Update 19
Feb 22, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Financial Results 21
Jan 09, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Operating Statistics and Preliminary Revenue 24
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 25
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 28
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 31
Corporate Communications 33
Aug 02, 2018: Novocure announces addition to its Board of Directors 33
May 31, 2018: Novocure Announces Changes to Its Board of Directors 34
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NovoCure Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novocure Enters into Agreement with US Oncology Research 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 12
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Ltd, Key Competitors 16
NovoCure Ltd, Key Employees 17
NovoCure Ltd, Subsidiaries 18

List of Figures
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intermountain Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hino Motors Ltd (7205):企業の財務・戦略的SWOT分析
    Hino Motors Ltd (7205) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Boliden AB:企業の戦略・SWOT・財務情報
    Boliden AB - Strategy, SWOT and Corporate Finance Report Summary Boliden AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CytoSorbents Corp (CTSO)-医療機器分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bri-Chem Corp. (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • 3M Co (MMM)-エネルギー分野:企業M&A・提携分析
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanot …
  • CFF GmbH & Co KG:戦略・SWOT・企業財務分析
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sixt SE:企業の戦略・SWOT・財務情報
    Sixt SE - Strategy, SWOT and Corporate Finance Report Summary Sixt SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • National Beverage Corp.:企業の戦略・SWOT・財務情報
    National Beverage Corp. - Strategy, SWOT and Corporate Finance Report Summary National Beverage Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Radiomedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that provides therapies. The company provides radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. Its products include smartmedix system and glucomedix. Radiomedix’s services include CGMP drug manufacturing suite and mi …
  • Aceto Corp (ACET):企業の財務・戦略的SWOT分析
    Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JCB Co., Ltd.:企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orig3N Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orig3N Inc (Orig3N), a biotechnology company that focuses on the research, development and treatment of genetically inherited diseases. The company offers DNA test kits which include SUPERHERO for analyzing strength, intelligence and speed; FITNESS that provides reports and analysis on vario …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Anthem, Inc.:企業の戦略・SWOT・財務情報
    Anthem, Inc. - Strategy, SWOT and Corporate Finance Report Summary Anthem, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆